glp-1 teeth Ozempic teeth” are raising concern among users of Ozempic and other drugs due to reports of dry mouth, bad breath, sensitivity, cavities, and gum inflammation. Although there is no conclusive evidence GLP-1 Medications and Dry Mouth:

and D.T

Work with your healthcare provider to compile baseline labs (BMI, vital signs, comorbid diagnoses, HbA1c if diabetic) and any prior weight-loss attemptswritten documentation strengthens prior authorization requests and speeds approval timelines

Despite Harvard Medical School research published in July 2024 showing diabetes patients prescribed semaglutide faced over four times higher NAION risk (and weight loss patients faced over seven times higher risk) Novo Nordisks current Ozempic and Wegovy labels still mention only generic vision changes without specifically identifying NAION or permanent blindness as known risks

P = 0.14

Moreover, increasing evidence postulates a production and paracrine role for small amounts of bioactive GLP-1 produced by pancreatic -cells (Nie et al

490 Mirikuzumab has been shown to have 48% subcutaneous bioavailability, although the bioavailability decreases with increasing BMI